Playback speed
×
Share post
Share post at current time
0:00
/
0:00
Transcript

Doctors, Patients, and Cannabis: Who’s Guiding Whom?

Rescheduling Cannabis: Progress Without Preparedness?

Cannabis Rescheduled: A Win or a Wild Card?

Share

Let’s talk about the government and cannabis—two words that, until recently, didn’t exactly go together. For decades, cannabis has been labeled as having “no medical value,” stuck in the same category as heroin. But now, the tide is turning. The government is finally catching up, admitting that cannabis might actually have a place in medicine. Sounds like progress, right? Well, kind of.

Here’s the twist: rescheduling cannabis isn’t as simple as flipping a switch. Sure, it’ll soon be easier for doctors to prescribe cannabis, like they would testosterone or steroids. But here’s the kicker—most doctors don’t know the first thing about cannabis. Only about 9% of medical schools in the U.S. teach anything about it. So, while patients are eager to explore its benefits, the very people who are supposed to guide them are left scratching their heads. It’s like handing someone a map with no directions and saying, “Good luck!”

For patients, especially seniors exploring cannabis as a safer alternative to opioids, this gap is more than frustrating—it’s risky. We’re talking about people trying to manage serious conditions like chronic pain and anxiety, often with little more than anecdotal advice to go on. And while rescheduling cannabis is a huge step forward, it also shines a spotlight on how far we still have to go. Patients need more than access—they need real guidance, rooted in science, not guesswork.

This could be the moment where everything changes—if we do it right. Imagine a future where cannabis care is just as precise and personalized as any other medical treatment. It’s not out of reach, but it’s going to take education, collaboration, and a willingness to reimagine how we think about healthcare. The potential is enormous, but so is the responsibility. What do you think? Are we ready to make this leap, or are we setting ourselves up for a whole new kind of chaos?


For more on the Commonwealth Project: https://commonwealthproject.org

For The Doctor-Approved Cannabis Handbook: Amazon | Gift a Signed Copy | AudioBook

Cannabis care made simple & accessible through telemedicine 👉 CEDclinic.com 💻


Don’t miss out! The first 25 to Like, Comment, and Re-Stack will get a free week of subscription access—because we’re cool like that. 😎

Loading...

Prefer YouTube?

Below the break: “Unpacking Cannabis Rescheduling: Insights into the Future of Medical Cannabis Care”

5 Kernels of Wisdom about Rescheduling and its Implications.

Physicians Lack Training in Cannabis Care

1. Many doctors feel unprepared to recommend or discuss cannabis due to a lack of formal education. A study in the Journal of the American Board of Family Medicine found that only a small percentage of physicians feel equipped to advise patients on medical cannabis use.

Source: Journal of the American Board of Family Medicine

2. Patients Often Drive the Conversation

Patients are frequently the ones bringing up cannabis as a treatment option, especially after trying conventional therapies without success. Research published in BMC Primary Care highlights that patient demand significantly influences how physicians view and approach medical cannabis.

Source: BMC Primary Care

3. State-Level Cannabis Programs Are Inconsistent

There is significant variability in how states structure and regulate medical cannabis programs, leading to unequal patient outcomes. A narrative review in Medical Cannabis and Cannabinoids suggests that standardized evaluations could help create best practices nationwide.

Source: Medical Cannabis and Cannabinoids

4. Residency Programs Fail to Cover Cannabis

Most family medicine residency programs do not include sufficient cannabis education. A study in Family Medicine emphasizes that this lack of training leaves new doctors uncomfortable discussing cannabis with patients.

Source: Family Medicine

5. Healthcare Providers Demand More Evidence

Healthcare professionals express concerns about the limited clinical guidelines and lack of robust evidence on cannabis, even as they see increasing patient interest. A scoping review in the Journal of Public Health highlights the pressing need for comprehensive research to fill these gaps.

Source: Journal of Public Health

Doctor-Approved Cannabis
Cannabis Insights Series
Here, I share in-depth insights and lessons drawn from published research and my extensive experience managing data from hundreds of thousands of patients. These are journeys that go beyond a single post, offering professional yet relatable guidance across multiple posts.